Geode Capital Management
HURA

Geode Capital Management’s TuHURA Biosciences HURA Stock Holding History

Geode Capital Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
484,219
-502,703
-51% -$1.17M ﹤0.01% 3325
2026
Q1 		$1.77M Buy
986,922
+324,441
+49% +$398K ﹤0.01% 3171
2025
Q4 		$501K Buy
662,481
+39,710
+6% +$76K ﹤0.01% 3583
2025
Q3 		$1.54M Buy
622,771
+39,779
+7% +$105K ﹤0.01% 3269
2025
Q2 		$1.3M Buy
582,992
+307,260
+111% +$1.04M ﹤0.01% 3254
2025
Q1 		$891K Buy
275,732
+10,817
+4% +$39.9K ﹤0.01% 3345
2024
Q4 		$1.08M Buy
264,915
+252,217
+1,986% +$1.34M ﹤0.01% 3347
2024
Q3 		$86.7K Buy
12,698
+2,872
+29% +$21.4K ﹤0.01% 4147
2024
Q2 		$92.9K Buy
9,826
+8,593
+697% +$53.5K ﹤0.01% 4156
2024
Q1 		$4.49K Hold
1,233
– – ﹤0.01% 4589
2023
Q4 		$7.32K Buy
1,233
+835
+210% +$43.2K ﹤0.01% 4614
2023
Q3 		$56.4K Sell
398
-3
-0.7% -$443 ﹤0.01% 4395
2023
Q2 		$56.6K Hold
401
– – ﹤0.01% 4480
2023
Q1 		$51.7K Sell
401
-3
-0.7% -$579 ﹤0.01% 4509
2022
Q4 		$97K Buy
404
+199
+97% +$44.2K ﹤0.01% 4413
2022
Q3 		$38K Hold
205
– – ﹤0.01% 4816
2022
Q2 		$99K Sell
205
-120
-37% -$52.3K ﹤0.01% 4598
2022
Q1 		$226K Buy
325
+29
+10% +$20.9K ﹤0.01% 4316
2021
Q4 		$264K Buy
296
+129
+77% +$174K ﹤0.01% 4354
2021
Q3 		$251K Buy
167
+8
+5% +$21K ﹤0.01% 4343
2021
Q2 		$630K Buy
159
+72
+83% +$207K ﹤0.01% 3828
2021
Q1 		$264K Buy
+87
New +$295K ﹤0.01% 4030

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Geode Capital Management's HURA Position: Q2 2026 in Review

Geode Capital Management reduced its TuHURA Biosciences (HURA) stake by 51% in Q2 2026, selling an estimated $1.17M and leaving 484,219 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #3325.

Geode Capital Management first reported a position in HURA in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.77M in Q1 2026. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Geode Capital Management held 484,219 shares of TuHURA Biosciences worth $1.13M as of Q2 2026.
  • Geode Capital Management sold 502,703 TuHURA Biosciences shares in Q2 2026, an estimated $1.17M.
  • TuHURA Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3325 holding.
  • Geode Capital Management first reported a position in TuHURA Biosciences in Q1 2021 and has held it in 22 quarters since.
  • Geode Capital Management's TuHURA Biosciences position peaked at $1.77M in Q1 2026.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.